ZIM
CRL icon

Zacks Investment Management’s Charles River Laboratories CRL Stock Holding History

Zacks Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17,462
Closed -$2.48M – 528
2019
Q2 		$2.48M Sell
17,462
-43
-0.2% -$5.83K 0.05% 229
2019
Q1 		$2.54M Sell
17,505
-1,683
-9% -$221K 0.05% 220
2018
Q4 		$2.17M Buy
19,188
+601
+3% +$75.2K 0.05% 221
2018
Q3 		$2.5M Buy
18,587
+975
+6% +$120K 0.05% 238
2018
Q2 		$1.98M Buy
17,612
+1,037
+6% +$112K 0.04% 278
2018
Q1 		$1.77M Buy
16,575
+1,448
+10% +$156K 0.04% 289
2017
Q4 		$1.66M Buy
15,127
+298
+2% +$32.4K 0.04% 306
2017
Q3 		$1.6M Buy
14,829
+1,736
+13% +$178K 0.04% 284
2017
Q2 		$1.32M Buy
13,093
+473
+4% +$43.5K 0.03% 304
2017
Q1 		$1.14M Buy
12,620
+858
+7% +$72.9K 0.03% 325
2016
Q4 		$896K Buy
11,762
+9
+0.1% +$684 0.03% 345
2016
Q3 		$980K Buy
11,753
+309
+3% +$25.9K 0.03% 332
2016
Q2 		$943K Sell
11,444
-2,811
-20% -$232K 0.03% 335
2016
Q1 		$1.08M Buy
+14,255
New +$1.06M 0.03% 306
2015
Q1 		– Sell
-3,972
Closed -$253K – 637
2014
Q4 		$253K Buy
+3,972
New +$249K 0.01% 541

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Zacks Investment Management's CRL Position: Q3 2019 in Review

Zacks Investment Management sold out of Charles River Laboratories (CRL) in Q3 2019, closing a stake of 17,462 shares — an estimated $2.48M sold.

Zacks Investment Management first reported a position in CRL in Q4 2014 and held it in 15 quarters. The position peaked at $2.54M in Q1 2019. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

  • Zacks Investment Management reported no remaining Charles River Laboratories position as of Q3 2019 after selling out during the quarter.
  • Zacks Investment Management sold 17,462 Charles River Laboratories shares in Q3 2019, an estimated $2.48M.
  • Zacks Investment Management first reported a position in Charles River Laboratories in Q4 2014 and held it in 15 quarters.
  • Zacks Investment Management's Charles River Laboratories position peaked at $2.54M in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Zacks Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.